Cargando…
Clinical Value of Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Levels in Term Neonates with Infection or Sepsis: A Prospective Study
Background. suPAR, the soluble form of the urokinase-type plasminogen activator receptor, has been identified as a biomarker of infection in adults but its properties in neonatal infection are not known. Methods. Plasma suPAR levels were determined by ELISA in 47 term neonates with infection (19 bac...
Autores principales: | Siahanidou, Tania, Margeli, Alexandra, Tsirogianni, Chrysanthi, Charoni, Stavroula, Giannaki, Maria, Vavourakis, Eustathios, Charisiadou, Athina, Papassotiriou, Ioannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026989/ https://www.ncbi.nlm.nih.gov/pubmed/24882949 http://dx.doi.org/10.1155/2014/375702 |
Ejemplares similares
-
Serum YKL-40 as a Potential Biomarker for Sepsis in Term Neonates—A Pilot Study
por: Steletou, Evangelia, et al.
Publicado: (2023) -
Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Induction
por: Terpos, Evangelos, et al.
Publicado: (2020) -
The accuracy of soluble urokinase-type plasminogen activator receptor for the diagnosis of neonatal sepsis: a meta-analysis
por: Ma, Jinjin, et al.
Publicado: (2023) -
Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor
por: Giamarellos-Bourboulis, Evangelos J, et al.
Publicado: (2012) -
Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)